產(chǎn)品名稱 Recombinant Human CCL17 (TARC) (ELISA Std.) from BIOLEGEND
    產(chǎn)品貨號 573809
    產(chǎn)品價格 現(xiàn)貨詢價,電話:010-67529703
    產(chǎn)品規(guī)格 4 pack
    產(chǎn)品品牌 BIOLEGEND
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameRecombinant Human CCL17 (TARC) (ELISA Std.)
    DescriptionCCL17 was initially isolated from phytohemagglutinin-stimulated PBMCs. CCL17 is constitutively expressed in the thymus and, under activation, in several cell types. CCL17-mediated recruitment of Th2 cells and CLA+ CD4+ T cells plays a key role in allergic diseases like atopic dermatitis, allergic asthma, allergic rhinitis, and allergic contact dermatitis. In addition, CCL17 has been detected in idiopathic pulmonary fibrosis. Also, CCL17 and CCL22 secreted by dendritic cells seem to mediate the recruitment of regulatory T cells to sites of inflammation in patients with chronic hepatitis. CCL17 is upregulated by several combinations of cytokines: TNF-α, IL-4, and IFN-γ in bronchial epithelial cells; TGF-β1, TNF-α, and IFN-γ in human keratinocyte cell lines; and histamine and prostaglandin E2P in immature dendritic cells.????
    Size4 pack
    Concentrationn/a
    ApplicationsELISA
    Other NamesThymus and activation-regulated chemokine (TARC), Small-inducible cytokine 17 (SCYA17), ABCD-2, ABCD2
    Gene, Accession, CAS #Gene ID: 6361
    Catalog #573809
    Price
    Order / More InfoRecombinant Human CCL17 (TARC) (ELISA Std.) from BIOLEGEND
    Product Specific Referencesn/a
    產(chǎn)品資料

    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>
  1. <th id="itm00"></th>